Physician profile
Hsin Li
NPI 1396247524
$2,247.66
in general payments reported to CMS, 2019-2025
20 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $38.88 · 2021: $172 · 2022: $34.81 · 2023: $877 · 2024: $504 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $586.28 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $372.75 | 2021-2025 | |
| Pfizer INC. | $336.08 | 2019-2025 | |
| Amgen INC. | $298.85 | 2021-2023 | Prolia, Evenity |
| Glaxosmithkline, LLC. | $156.44 | 2019-2023 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $99.07 | 2024-2025 | Airsupra |
| Lilly USA, LLC | $72.04 | 2023-2025 | Zepbound, Mounjaro |
| Astellas Pharma US INC | $42.69 | 2024 | Veozah |
| Merck Sharp & Dohme LLC | $42.45 | 2023-2025 | Verquvo, Vaqta, Capvaxive |
| Abbott Laboratories | $35.79 | 2023-2024 | Freestyle Libre 3 |
| Phadia US INC. | $31.72 | 2023-2024 | Immunocap |
| Hologic Sales and Service, LLC | $23.97 | 2023 | Thinprep 2000 Processor |
| Esperion Therapeutics, INC. | $21.65 | 2024 | Nexletol |
| Sumitomo Pharma America, INC. | $21.14 | 2025 | Myfembree |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.73 | 2024 | Jardiance |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $20.23 | 2023 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $19.83 | 2019 | |
| Abbvie INC. | $19.43 | 2023 | |
| Amarin Pharma, INC. | $13.47 | 2020 | |
| Kaleo, INC. | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hsin Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.